Improvement of nephrotoxicity, hypertension, and lipid metabolism after conversion of kidney transplant recipients from cyclosporine to tacrolimus

MeSH terms

• Adult
• Aged
• Azathioprine / therapeutic use
• Blood Pressure / drug effects
• Cholesterol / blood
• Cholesterol, HDL / blood
• Cholesterol, LDL / blood
• Cyclosporine / adverse effects*
• Cyclosporine / therapeutic use
• Drug Therapy, Combination
• Graft Rejection / epidemiology
• Graft Rejection / prevention & control
• Humans
• Hypertension / chemically induced*
• Hypertension / prevention & control
• Immunosuppressive Agents / adverse effects*
• Immunosuppressive Agents / therapeutic use
• Incidence
• Kidney Transplantation / immunology*
• Kidney Transplantation / pathology*
• Kidney Transplantation / physiology
• Lipids / blood*
• Middle Aged
• Prednisolone / therapeutic use
• Tacrolimus / adverse effects*
• Tacrolimus / therapeutic use
• Triglycerides / blood